MARKET WIRE NEWS

Generics Stalwart Teva Has Turned A Corner In Its Specialty Medicines Business

Source: SeekingAlpha

2025-11-14 10:38:47 ET

Thesis

Teva Pharmaceutical Industries Limited ( TEVA ), founded in 1901 and based in Israel, has developed into one of the world’s leading generics drug companies. They rank closely with Sandoz ( SDZNY ), Viatris ( VTRS ) – formed in 2020 as a merger between Upjohn and Mylan – Sun Pharma, and Dr. Reddy’s ( RDY ), all of which have developed over several decades the capacity to leverage their size and manufacturing capabilities to claim a decent share of the market. These companies operate a kind of oligopoly in this niche space....

Read the full article on Seeking Alpha

For further details see:

Generics Stalwart Teva Has Turned A Corner In Its Specialty Medicines Business
Alvotech

NASDAQ: ALVO

ALVO Trading

1.39% G/L:

$3.65 Last:

246,832 Volume:

$3.55 Open:

mwn-alerts Ad 300

ALVO Latest News

March 30, 2026 07:55:00 pm
Alvotech Files Annual Report with the SEC

ALVO Stock Data

$1,569,389,520
107,654,085
N/A
30
N/A
Pharmaceuticals
Healthcare
LU
Luxembourg

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App